Effect of smoking on disease activity in multiple sclerosis patients treated with dimethyl fumarate or fingolimod.

Eizo Tanaka,Mitsuru Watanabe,Shoko Fukumoto,Katsuhisa Masaki,Ryo Yamasaki,Takuya Matsushita,Noriko Isobe

Multiple sclerosis and related disorders（2023）

引用 0|浏览8

暂无评分

摘要

Smoking was a risk factor for disease activity in RRMS patients under oral DMD treatment. RRMS patients should be advised to stop smoking even after the initiation of DMDs.

查看译文

关键词

Dimethyl fumarate,Fingolimod,Multiple sclerosis,Oral disease-modifying drug,Relapse,Smoking

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要